BIO
BIO-RAD LABORATORIES, INC.Price
Daily candles with volume. Callouts mark insider and congressional trades, rating changes, 13F stakes, reports, catalysts, court and regulator actions, Reddit spikes and short-interest jumps. Hover one for the details (tap on phones).
- Sep 10 Brandeis University v. Bio-Rad Laboratories, Inc.
- Nov 4 ▲ Earnings: BIO Q3 2026 Earnings: EPS $2.65 (+17.9% vs est)
- Nov 9 to Nov 10 ▼ 2 days of insider sells: $1.2M by 3 insiders, avg $387.16
Signal stack
Where each data set points today.
- InsidersBEARISH
3 insiders sold $1.2M.
- InstitutionsMIXED
Q3 2026: 30 added (1 new), 28 trimmed or exited.
- AnalystsBULLISH
5 of 10 rate it Buy or better. Median target $350.00 (−3%).
- Short sellersSTEADY
Short interest +5.4% to 1.16M shares. 5.1 days to cover, ≈4.3% of shares.
- TrendRANGE
3% below its 50-day average.
Who's buying
13F· Q3 2026| Fund | Move | Value |
|---|---|---|
| Capital Research Global Investors | ADD | $225.2M |
| Neuberger Berman Group LLC | DOUBLED | $149.6M |
| MORGAN STANLEY | ADD | $116.0M |
| FMR LLC | DOUBLED | $83.1M |
| VICTORY CAPITAL MANAGEMENT INC | ADD | $71.0M |
| Assenagon Asset Management S.A. | TRIM | $55.7M |
| MARSHALL WACE, LLP | DOUBLED | $25.7M |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | DOUBLED | $25.1M |
Quarterly 13F filings are due 45 days after each quarter ends.
The Street
10 analystsPrice is inside the target range. Median implies −3%.Targets as of Nov 17, 2026.
| Date | Firm | Rating |
|---|---|---|
| Nov 5, 2026 | RBC Capital MAINTAIN | Outperform |
| Aug 7, 2026 | RBC Capital MAINTAIN | Outperform |
| Aug 5, 2026 | Citigroup MAINTAIN | Neutral |
| Aug 5, 2026 | RBC Capital MAINTAIN | Outperform |
| Aug 5, 2026 | Wells Fargo MAINTAIN | Equal-Weight |
Insider ledger
Form 4| Insider | Type | Value |
|---|---|---|
ENLOE COURTNEY C EVP, General Counsel & Sec Nov 10, 2026 | SELL | $348.3K |
DiVincenzo Jonathan P. President & COO Nov 9, 2026 | SELL | $358.8K |
BARRY JAMES EVP, President, LSG Nov 9, 2026 | SELL | $539.9K |
DiVincenzo Jonathan P. President & COO Oct 24, 2026 | EXERCISE | 1,869 sh |
DiVincenzo Jonathan P. President & COO Oct 24, 2026 | TAX W/H | $351.8K |
EVRAN SEDAT EVP, Global Supply Chain Oct 20, 2026 | TAX W/H | $172.6K |
EVRAN SEDAT EVP, Global Supply Chain Oct 20, 2026 | EXERCISE | 1,044 sh |
BARRY JAMES EVP, President, LSG Sep 6, 2026 | EXERCISE | 1,056 sh |
Earnings setup
EstimatesRevision history: 🔒 Fresh data, subscribers only
| Period | EPS est. | Range | 30D rev. | Revenue |
|---|---|---|---|---|
| Current Q | 🔒 Fresh data, subscribers only | |||
| Next Q | 🔒 Fresh data, subscribers only | |||
| Current FY | 🔒 Fresh data, subscribers only | |||
| Next FY | 🔒 Fresh data, subscribers only | |||
Washington
Short side
FINRA· Oct 30, 2026SecBot reports
9 filings · 0 bullish · 2 bearish · 2 mixed · 5 neutral- NEUTRAL CLUSTERNov 12, 2026
Two senior executives at Bio-Rad (President & COO and EVP/President of Life Science Group) sold a…
The sales are very small relative to market cap and follow a positive earnings report, making them likely routine portfolio adjustments. Monitor for any larger insider selling or changes in forward…
- NEUTRAL 144Nov 10, 2026
Courtney Enloe, an officer of Bio-Rad Laboratories, filed a Form 144 notice of intent to sell 902…
The filing is a routine insider intent-to-sell notice for a small number of shares. No material impact expected. Monitor for actual sale execution on Form 4, but this is unlikely to signal any…
- NEUTRAL 144Nov 9, 2026
Jonathan P. DiVincenzo, an officer of Bio-Rad Laboratories, filed a Form 144 notice of intent to…
This is a routine insider intent-to-sell filing with immaterial size. Monitor for any subsequent Form 4 filings to confirm execution, but no further action warranted.
- NEUTRAL 144Nov 9, 2026
James Barry, an officer of Bio-Rad Laboratories, filed a Form 144 notice of intent to sell 1,400…
This is a small, routine insider sale by an officer following restricted stock vesting. No material impact on the stock is expected. Monitor for any subsequent Form 4 filings to confirm execution.
All BIO filing & press-release reports (9)
- CLUSTER reportNov 12, 2026
- 144 reportNov 10, 2026
- 144 reportNov 9, 2026
- 144 reportNov 9, 2026
- INST-CLUSTER reportNov 6, 2026
- 8-K reportNov 4, 2026
- INST-CLUSTER reportOct 27, 2026
- COURT-RULING reportSep 10, 2026
- INST-CLUSTER reportJun 12, 2026